Sequencing data is all well and good, but what does it mean?
Bayer's only remaining medical technology franchise is its radiology business.
Regulatory intervention having limited impact on fostering innovation.
Nine IPOs have got away so far this year, and one of them is very big indeed.
The first quarter of this year saw more venture funding raised by medical device groups than any other period since 2010.
A return to tuck-in deals – sort of.
Smaller medtechs saw impressive share price growth in 2018, but not quite as good as the year before.
Big cap medtech disappoints – but still beats pharma.
GE arrives to the spin-out party fashionably late.